Medicus Pharma Ltd. GAAP EPS of -$0.31
Seeking Alpha News (Thu, 14-May 4:51 PM ET)
Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
Globe Newswire (Thu, 14-May 4:30 PM ET)
Globe Newswire (Wed, 6-May 7:30 AM ET)
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
Globe Newswire (Mon, 27-Apr 7:30 AM ET)
Medicus Pharma Targets Unmet Need with Orphan Drug Application for SkinJect in Gorlin Syndrome
Market Chameleon (Fri, 17-Apr 7:45 AM ET)
Globe Newswire (Fri, 17-Apr 7:30 AM ET)
Globe Newswire (Wed, 15-Apr 7:30 AM ET)
Globe Newswire (Mon, 6-Apr 7:30 AM ET)
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
Globe Newswire (Wed, 1-Apr 7:30 AM ET)
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
Globe Newswire (Mon, 30-Mar 7:30 AM ET)
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
Medicus Pharma Ltd. trades on the NASDAQ stock market under the symbol MDCX.
As of May 15, 2026, MDCX stock price declined to $0.30 with 1,262,996 million shares trading.
MDCX has a beta of 2.77, meaning it tends to be more sensitive to market movements. MDCX has a correlation of 0.03 to the broad based SPY ETF.
MDCX has a market cap of $16.60 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that MDCX belongs to (by Net Assets): IWC.
MDCX has underperformed the market in the last year with a return of -94.9%, while the SPY ETF gained +26.4%. In the last 3 month period, MDCX fell short of the market, returning -71.6%, while SPY returned +8.7%. However, in the most recent 2 weeks MDCX has outperformed the stock market by returning +5.5%, while SPY returned +2.6%.
MDCX support price is $.31 and resistance is $.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDCX shares will trade within this expected range on the day.
